1. Home
  2. GKOS vs LSTR Comparison

GKOS vs LSTR Comparison

Compare GKOS & LSTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • LSTR
  • Stock Information
  • Founded
  • GKOS 1998
  • LSTR 1991
  • Country
  • GKOS United States
  • LSTR United States
  • Employees
  • GKOS 995
  • LSTR N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • LSTR Trucking Freight/Courier Services
  • Sector
  • GKOS Health Care
  • LSTR Industrials
  • Exchange
  • GKOS Nasdaq
  • LSTR Nasdaq
  • Market Cap
  • GKOS 5.1B
  • LSTR 5.4B
  • IPO Year
  • GKOS 2015
  • LSTR 1993
  • Fundamental
  • Price
  • GKOS $90.26
  • LSTR $137.82
  • Analyst Decision
  • GKOS Strong Buy
  • LSTR Hold
  • Analyst Count
  • GKOS 13
  • LSTR 14
  • Target Price
  • GKOS $155.00
  • LSTR $156.09
  • AVG Volume (30 Days)
  • GKOS 1.0M
  • LSTR 429.3K
  • Earning Date
  • GKOS 04-30-2025
  • LSTR 04-29-2025
  • Dividend Yield
  • GKOS N/A
  • LSTR 2.48%
  • EPS Growth
  • GKOS N/A
  • LSTR N/A
  • EPS
  • GKOS N/A
  • LSTR 5.51
  • Revenue
  • GKOS $383,481,000.00
  • LSTR $4,834,055,000.00
  • Revenue This Year
  • GKOS $27.84
  • LSTR $5.15
  • Revenue Next Year
  • GKOS $27.99
  • LSTR $9.27
  • P/E Ratio
  • GKOS N/A
  • LSTR $24.95
  • Revenue Growth
  • GKOS 21.85
  • LSTR N/A
  • 52 Week Low
  • GKOS $77.91
  • LSTR $128.99
  • 52 Week High
  • GKOS $163.71
  • LSTR $196.86
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 41.57
  • LSTR 41.28
  • Support Level
  • GKOS $86.16
  • LSTR $133.45
  • Resistance Level
  • GKOS $94.55
  • LSTR $144.52
  • Average True Range (ATR)
  • GKOS 6.54
  • LSTR 6.26
  • MACD
  • GKOS 1.11
  • LSTR -0.01
  • Stochastic Oscillator
  • GKOS 54.51
  • LSTR 36.50

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About LSTR Landstar System Inc.

Landstar System is an agent based asset-light third-party logistics provider focused on domestic truck brokerage (90% of revenue). Historically, around half of its truck transportation freight is hauled by leased owner-operators with the remainder hauled by third-party broker-carriers. To a smaller degree, it offers intermodal, global air and ocean forwarding, and warehousing services. Landstar also runs a small business that offers insurance programs to captive owner-operators. It has a long history of industry-leading execution and operating profitability.

Share on Social Networks: